Nurse Practitioner, Family · Chattanooga, TN
NPI
1356684369
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5616 Brainerd Rd, Suite 208
Chattanooga, TN, 37411
Phone (423) 265-3561
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,333
34 services
Medicare patients, 2024
27
Average age 77
Drug cost, 2024
$1.5M
2,611 prescriptions
Company payments, 2025
$535
From 16 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jamie H Moses prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 188 prescriptions and refills. In total Jamie H Moses wrote 2,611 Medicare prescriptions that cost $1.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Mounjaro Tirzepatide | 188 | 225 | 31 | $228K |
| Ozempic Semaglutide | 182 | 357 | 57 | $334K |
| Levothyroxine Sodium Generic | 170 | 489 | 53 | $1,360 |
| Metformin Hcl Er Metformin Hcl | 131 | 375 | 44 | $1,684 |
| Atorvastatin Calcium Generic | 110 | 325 | 39 | $1,611 |
| Novolog Insulin Aspart | 90 | 169 | 29 | $56K |
| Rosuvastatin Calcium Generic | 77 | 221 | 26 | $1,721 |
| Novolog Flexpen Insulin Aspart | 71 | 160 | 32 | $45K |
| Glimepiride Generic | 66 | 146 | 15 | $635 |
| Farxiga Dapagliflozin Propanediol | 55 | 145 | 18 | $79K |
| Gabapentin Generic | 54 | 144 | 23 | $947 |
| Tresiba Flextouch U-200 Insulin Degludec | 51 | 114 | 19 | $122K |
| Amlodipine Besylate Generic | 48 | 141 | 14 | $439 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 45 | 93 | 13 | $78K |
| Synthroid Levothyroxine Sodium | 42 | 117 | 13 | $4,730 |
Brand drugs: 1,205 claims; generic drugs: 1,229 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jamie H Moses $535 ($535 in general payments such as food, travel and fees) from 16 companies. The largest payer was Beta Bionics, Inc. with $107.
| Company | Payments | Amount |
|---|---|---|
| Beta Bionics, Inc. BBNX | 1 | $107 |
| Dexcom, Inc. DXCM | 2 | $51.91 |
| Sequel Med Tech, LLC | 2 | $47.71 |
| Xeris Pharmaceuticals, Inc. | 2 | $41.26 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $39.03 |
| Tandem Diabetes Care, Inc. TNDM | 2 | $33.21 |
| Boston Scientific Corporation BSX | 1 | $29.14 |
| Insulet Corporation PODD | 1 | $28.02 |
| CeQur Corporation | 1 | $25.93 |
| CVRx, Inc. CVRX | 1 | $24.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.